efficacy, safety and tolerability of escitalopram in doses up to 50 mg in major depressive disorder (mdd) an open-label, pilot study有效性、安全性和耐受性的酞剂量高达50毫克的重度抑郁症(mdd)一个非盲、试点研究.pdfVIP

  • 4
  • 0
  • 约5.34万字
  • 约 9页
  • 2017-09-06 发布于上海
  • 举报

efficacy, safety and tolerability of escitalopram in doses up to 50 mg in major depressive disorder (mdd) an open-label, pilot study有效性、安全性和耐受性的酞剂量高达50毫克的重度抑郁症(mdd)一个非盲、试点研究.pdf

efficacy, safety and tolerability of escitalopram in doses up to 50 mg in major depressive disorder (mdd) an open-label, pilot study有效性、安全性和耐受性的酞剂量高达50毫克的重度抑郁症(mdd)一个非盲、试点研究

Wade et al. BMC Psychiatry 2011, 11:42 /1471-244X/11/42 RESEARCH ARTICLE Open Access Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study 1* 1 2 Alan G Wade , Gordon M Crawford , Ann Yellowlees Abstract Background: Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档